Genmab A/S

NASDAQ: GMAB · Real-Time Price · USD
23.29
0.31 (1.35%)
At close: Aug 15, 2025, 3:59 PM
23.28
-0.02%
After-hours: Aug 15, 2025, 07:09 PM EDT

Genmab A/S Cash Flow Statement

Financials in DKK. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
7.84B 5.64B 7.04B 3.98B
Depreciation & Amortization
413M 295M 362M 248M
Stock-Based Compensation
721M 586M 439M 310M
Other Working Capital
n/a n/a -90M n/a
Other Non-Cash Items
388M -622M -1.99B -997M
Deferred Income Tax
n/a 122M n/a -546M
Change in Working Capital
-1.59B 1.36B -1.93B -770M
Operating Cash Flow
7.77B 7.38B 3.91B 2.23B
Capital Expenditures
-187M -376M -317M -252M
Cash Acquisitions
-12.25B n/a 2.44B 709M
Purchase of Investments
-8.64B -10.91B -9.7B -15.62B
Sales Maturities Of Investments
11.28B 10B 7.25B 14.91B
Other Investing Acitivies
-117M -10M -2.44B -709M
Investing Cash Flow
-9.91B -1.28B -2.76B -961M
Debt Repayment
-60M -91M -73M -58M
Common Stock Repurchased
-3.99B -564M -908M -447M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
129M 49M 192M 85M
Financial Cash Flow
-3.92B -606M -789M -420M
Net Cash Flow
-5.01B 4.97B 936M 1.7B
Free Cash Flow
7.58B 7B 3.6B 1.98B